| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.33 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |